PharmaEssentia Corporation
6446
Classificação em ações
#1449
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Preço da ação
$35.96
Valor de mercado
$14.87B
Variação (1 dia)
-0.85%
Variação (1 ano)
138.77%
País
TW
Negociar PharmaEssentia Corporation (6446)
Categoria
Healthcare
Histórico de preços das ações de PharmaEssentia Corporation (6446)
Preço de fecho mais alto: $37.51 em 2026-10-01
Preço de fecho mais baixo: $4.95 em 2014-03-01
Preço de fecho mais baixo: $4.95 em 2014-03-01
Histórico de preços das ações da PharmaEssentia Corporation de 2014 a 2026
Desempenho anual do preço das ações
| Ano | Desempenho |
|---|---|
| 2026 (TTM) | 78.21% |
| 2025 | -1.54% |
| 2024 | 65.30% |
| 2023 | -34.57% |
| 2022 | 52.79% |
| 2021 | 220.53% |
| 2020 | 2.39% |
| 2019 | -41.63% |
| 2018 | 21.23% |
| 2017 | -8.25% |
| 2016 | -3.31% |
| 2015 | 21.68% |
| 2014 | 0.00% |
Preço das ações de empresas similares ou concorrentes
| Empresa | Preço da ação | Variação 1a% | País |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $163.17 | 22.03% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $222.44 | 29.90% |
CH
|
|
| $18.46 | -3.88% |
IN
|
